Harvard Bioscience Inc (HBIO)
2.08
-0.02
(-0.95%)
USD |
NASDAQ |
Dec 24, 16:00
Harvard Bioscience Cash from Investing (Quarterly): -1.111M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp | -67.60M |
| Azenta Inc | 195.33M |
| Bionano Genomics Inc | -5.375M |
| Akoya Biosciences Inc | 13.02M |
| Singular Genomics Systems Inc | 42.29M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.842M |
| Cash from Financing (Quarterly) | 2.104M |
| Free Cash Flow | 0.16M |
| Free Cash Flow Per Share (Quarterly) | -0.0448 |
| Free Cash Flow to Equity (Quarterly) | -4.131M |
| Free Cash Flow to Firm (Quarterly) | -1.038M |
| Free Cash Flow Yield | 0.18% |